These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11478418)

  • 1. Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET.
    Lauer M; Schirrmeister H; Gerhard A; Ellitok E; Beckmann H; Reske SN; Stöber G
    J Neural Transm (Vienna); 2001; 108(6):661-70. PubMed ID: 11478418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive Therapy in a Patient With Chronic Catatonia: Clinical Outcomes and Cerebral 18[F]Fludeoxyglucose Positron Emission Tomography Findings.
    Pigato G; Roiter B; Cecchin D; Morbelli S; Tenconi E; Minelli A; Bortolomasi M
    J ECT; 2016 Dec; 32(4):222-223. PubMed ID: 27356089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
    Elkashef AM; Doudet D; Bryant T; Cohen RM; Li SH; Wyatt RJ
    Psychiatry Res; 2000 Nov; 100(1):1-11. PubMed ID: 11090720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.
    Parellada E; Lomena F; Font M; Pareto D; Gutierrez F; Simo M; Fernández-Egea E; Pavia J; Ros D; Bernardo M
    Nucl Med Commun; 2008 Oct; 29(10):894-900. PubMed ID: 18769307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-convulsive status epilepticus manifesting as ictal catatonia: a case report].
    Sanada Y; Kajikawa S; Kobayashi K; Kuzuya A; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2021 Jun; 61(6):385-391. PubMed ID: 34011811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-FDG PET study.
    Tatsch K; Koch W; Linke R; Poepperl G; Peters N; Holtmannspoetter M; Dichgans M
    J Nucl Med; 2003 Jun; 44(6):862-9. PubMed ID: 12791811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
    Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
    Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.
    Picco A; Morbelli S; Piccardo A; Arnaldi D; Girtler N; Brugnolo A; Bossert I; Marinelli L; Castaldi A; De Carli F; Campus C; Abbruzzese G; Nobili F
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1062-70. PubMed ID: 25820675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of cerebral glucose hypometabolism on positron emission tomography with electroconvulsive therapy in an elderly patient with a psychotic episode.
    Hassamal S; Jolles P; Pandurangi A
    Psychogeriatrics; 2016 Nov; 16(6):376-381. PubMed ID: 26756319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.
    Cheesman AL; Barker RA; Lewis SJ; Robbins TW; Owen AM; Brooks DJ
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1204-10. PubMed ID: 16107352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-Dopa as an amino acid tracer to detect brain tumors.
    Heiss WD; Wienhard K; Wagner R; Lanfermann H; Thiel A; Herholz K; Pietrzyk U
    J Nucl Med; 1996 Jul; 37(7):1180-2. PubMed ID: 8965194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
    Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual hallucination in Parkinson's disease with FDG PET.
    Nagano-Saito A; Washimi Y; Arahata Y; Iwai K; Kawatsu S; Ito K; Nakamura A; Abe Y; Yamada T; Kato T; Kachi T
    Mov Disord; 2004 Jul; 19(7):801-806. PubMed ID: 15254938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.